September 29, 2016
Landing, New Jersey — DolCas Biotech, LLC, has taken proactive actions in the form of a successful trademark-infringement suit to ensure its customers and consumers receive only the purest, truest turmeric. The forced legal action was taken to provide security to the consumer.
Three competitors, including contract manufacturers, agreed with Dolcas to all conditions settling the infringement of its US trademark for BCM-95® turmeric extract. The infringement on the BCM-95 brand had potential to impact consumer perception and hurt BCM-95’s leading position in the market.
The committee found novelty in the patented turmeric extract ingredients, also taking into consideration the Intellectual Properties ingredient is backed by more than 30 clinical research studies conducted in leading universities and institutes worldwide. The committee concluded that DolCas is entitled to protection of its brands and trademarks.
“BCM-95 and Bio Curcumin® are registered trademarks of DolCas Biotech globally and we intend to protect them for the safety and security of consumers and of our brands,” explains KG Rao, CEO of DolCas. “The three companies have now promised not to use our trademarks in the market and have completed the payments for the infringement. The payments will, in part, be applied to continued research into the multiple health benefits and efficacy of our line of pure turmeric extracts.”
The company estimates that BCM-95® turmeric extract has a market share of 30% in the US, and it has an exclusive contract with EuroPharma to market BCM-95 at health food stores in the US/Canada. “Terry Naturally Inc.’s CuraMed brand ‘Super Absorption Curcumin’ with BCM-95is the No. 1 brand in health food stores, and one of six CuraMed curcumin products in the top 10 sold,” notes Terry Lemerond, founder and president of EuroPharma, Inc.
“DolCas knows how to build a trusted brand. “Consumers, especially Millennials, want to know where their turmeric extract comes from, and they deserve a pure, trusted brand,” contributes Lemerond.
“We identified six keys to build a trusted brand in the US market,” explains Rao. “These are: a clear understanding of the ingredient advantages; an ongoing clinical research program; registered intellectual properties and trademarks; full control of the product from farm to shelf; the highest purity and safety; and long-lasting collaboration with customers. We intend to continue to invest in our clinical research program and to protect our brand from imitation products that might not be safe to sell or consume.”
Founded in 2007, DolCas Biotech, markets branded natural, guaranteed highly pure, patented ingredients guaranteed highly pure, with efficacy backed by scientific research. In partnership with Arjuna Natural Extracts, India, the company combines innovation with industry expertise to develop and patent unique healthy ingredients. Comprehensive research and testing allows Dolcas to consistently provide customers with trustworthy nutraceutical ingredient systems.